Skip to main content

Advertisement

SpringerLink
Log in

A Rare Case of Paraneoplastic Hypoglycemia Induced by Abdominopelvic Gastrointestinal Stromal Tumor

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Abbreviations

CT scan:

Computerized tomography scan

D50:

50% Dextrose

DNS:

Dextrose normal saline

ECOG PS:

Eastern Cooperative Oncology Group performance status

GIST:

Gastrointestinal stromal tumor

GISTH:

GIST associated with hypoglycemia

HbA1c:

Glycated hemoglobin

IGFBP-III:

Insulin growth factor–binding protein III

IGF-I:

Insulin-like growth factor I

IGF-II:

Insulin-like growth factor II

LCA:

Leukocyte common antigen

NICTH:

Non-islet cell tumor–associated hypoglycemia

OHA:

Oral hypoglycemic agents

USG:

Ultrasonography

References

  1. Mietinnen M, Lasota J. Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001;438:1–12.

    Article  Google Scholar 

  2. Rubin BP, Heinrich MC, Corless CL. Gastrointestinal stromal tumour. Lancet. 2007;369:1731–41.

    Article  CAS  Google Scholar 

  3. Steigen SE, Eide TJ. Gastrointestinal stromal tumors (GISTs): a review. APMIS. 2009;117:73–86.

    Article  Google Scholar 

  4. Beckers MM, Slee PH, van Doorn J. Hypoglycaemia in a patient with a gastrointestinal stromal tumor. Clin Endocrinol. 2003;59:402–4.

    Article  CAS  Google Scholar 

  5. Bodnar TW, Acevedo MJ, Pietropaolo M. Management of non-islet-cell tumor hypoglycemia: a clinical review. J Clin Endocrinol Metab. 2014;99:713–22.

    Article  CAS  Google Scholar 

  6. Rikhof B, van Doorn J, Suurmeijer AJH, Rautenberg MW, Groenen PJTA, Verdijk MAJ, et al. Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour. Ann Oncol. 2009;20(9):1582–8.

    Article  CAS  Google Scholar 

  7. Nadler WH, Wolfer JA. Hepatogenic hypoglycemia associated with primary liver cell carcinoma. Arch Intern Med. 1929;44:700–5.

    Article  CAS  Google Scholar 

  8. Davda R, Seddon BM. Mechanisms and management of non-islet cell tumour hypoglycaemia in gastrointestinal stromal tumour: case report and a review of published studies. Clin Oncol. 2007;19:265–8.

    Article  CAS  Google Scholar 

  9. Saeed Z, Taleb S, Evans-Molina C. A case of extragastrointestinal stromal tumor complicated by severe hypoglycemia: a unique presentation of a rare tumor. BMC Cancer. 2016;16(1):930.

    Article  Google Scholar 

  10. Pink D, Schoeler D, Lindner T, Thuss-Patience PC, Kretzschmar A, Knipp H, et al. Severe hypoglycemia caused by paraneoplastic production of IGF-II in patients with advanced gastrointestinal stromal tumors: a report of two cases. J Clin Oncol. 2005;23(27):6809–11.

    Article  Google Scholar 

  11. Escobar GA, Robinson WA, Nydam TL, Heiple DC, Weiss GJ, Buckley L, et al. Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report. BMC Cancer. 2007;7(1):13.

    Article  Google Scholar 

  12. Hirai H, Ogata E, Ohki S, Fukuda I, Tanaka M, Watanabe T, et al. Hypoglycemia associated with a gastrointestinal stromal tumor producing high-molecular-weight insulin growth factor II: a case report and literature review. Intern Med. 2016;55(10):1309–14.

    Article  CAS  Google Scholar 

  13. Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94:709–28.

    Article  CAS  Google Scholar 

  14. Nielsen TO, West RB, Linn SC, et al. Molecular characterisation of soft tissue tumors: a gene expression study. Lancet. 2002;359(9314):1301–7.

    Article  CAS  Google Scholar 

  15. Hamberg P, de Jong FA, Boonstra JG, van Doorn J, Verweij J, Sleijfer S. Non-islet-cell tumor induced hypoglycaemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinib. J Clin Oncol. 2006;24:e30–1.

    Article  Google Scholar 

  16. Dynkevich Y, Rother KI, Whitford I, Qureshi S, Galiveeti S, Szulc AL, et al. Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive. Endocr Rev. 2013;34:798–826.

    Article  CAS  Google Scholar 

  17. Coronado JA, Chávez MÁ, Manrique MA, Cerna J, Trejo AL. Retroperitoneal epithelioid sarcoma: a case report. World J Gastrointest Endosc. 2017;9(12):579–82.

    Article  Google Scholar 

  18. Hawasli JA, Hopping JR, Hsueh EC. Hypoglycemia with a large retroperitoneal mass – case report. Int J Surg Case Rep. 2014;5(12):1225–8.

    Article  Google Scholar 

  19. Tsakonas GP, Kallistratos MS, Balamoti EK, Gassiamis A, Zizi-Sermpetzoglou A, Mylonakis N, et al. Rare and aggressive metastatic, axial multifocal local epithelioid sarcoma associated with paraneoplastic granulocytosis and hypoglycaemia. Lancet Oncol. 2007;8(1):82–4.

    Article  Google Scholar 

  20. Takane K, Midorikawa Y, Yamazaki S, Kajiwara T, Yoshida N, Kusumi Y, et al. Gastrointestinal stromal tumor with nephrotic syndrome as a paraneoplastic syndrome: a case report. J Med Case Rep. 2014;8:108.

    Article  Google Scholar 

  21. Tsikrikas S, Manolakopoulos S, Deutsch M, Alexakis G, Sialevris K, Giannopoulos D, et al. Unusual combination of paraneoplastic manifestations in a patient with metastatic gastrointestinal stromal tumor (GIST). Scand J Gastroenterol. 2008;43(8):1012–5.

    Article  CAS  Google Scholar 

  22. Dogu GG, Dikilitas M, Ozkan M, Karahan OI, Karaca Z, Gunay N, et al. Hypoglycemia in a patient with metastatic gastrointestinal stromal tumor: is chemotherapy a reasonable option for symptom control? 2010;20(1):4.

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Dr. BRA-IRCH, All India Institute of Medical Sciences, New Delhi, India

    Navin Kumar, Sandeep Bhoriwal & S. V. S. Deo

  2. Department of Pathology, All India Institute of Medical Sciences, New Delhi, India

    Prasenjit Das

Authors
  1. Navin Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandeep Bhoriwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prasenjit Das
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. V. S. Deo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Navin Kumar.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Informed Consent

Informed consent was provided by the patient reported in this manuscript. The research was exempted from the need for review by the Institutional Ethics Committee. All figures are original and have not previously been published yet in any literature.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kumar, N., Bhoriwal, S., Das, P. et al. A Rare Case of Paraneoplastic Hypoglycemia Induced by Abdominopelvic Gastrointestinal Stromal Tumor. J Gastrointest Canc 51, 1065–1069 (2020). https://doi.org/10.1007/s12029-020-00406-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-020-00406-y

Search

Navigation